Volume 6, Issue 6, Pages (June 2010)

Slides:



Advertisements
Similar presentations
Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network Aviva Presser Aiden, Miguel N. Rivera, Esther Rheinbay,
Advertisements

DNA Methylation Regulates Gene Expression in Intracranial Aneurysms
GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes during Early Embryoid Body Differentiation  Li Wang, Evangelia Koutelou, Calley.
Cancer: Inappropriate Expression of Stem Cell Programs?
Chromatin Control of Developmental Dynamics and Plasticity
Volume 4, Issue 6, Pages (June 2009)
Volume 2, Issue 4, Pages (April 2008)
Volume 15, Issue 2, Pages (August 2014)
Volume 3, Issue 4, Pages (October 2008)
High-Resolution Profiling of Histone Methylations in the Human Genome
Volume 11, Issue 2, Pages (August 2012)
Wing Y. Chang, William L. Stanford  Cell Stem Cell 
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 44, Issue 3, Pages (November 2011)
A twin approach to unraveling epigenetics
Volume 26, Issue 4, Pages (October 2014)
Volume 44, Issue 1, Pages (October 2011)
Volume 17, Issue 6, Pages (December 2015)
Volume 17, Issue 4, Pages (October 2015)
Volume 8, Issue 1, Pages (January 2011)
Volume 9, Issue 3, Pages (September 2017)
Volume 2, Issue 2, Pages (February 2008)
High-Resolution Profiling of Histone Methylations in the Human Genome
Volume 10, Issue 6, Pages (June 2018)
Volume 17, Issue 8, Pages (November 2016)
Volume 10, Issue 1, Pages (January 2018)
Volume 23, Issue 1, Pages 9-22 (January 2013)
Volume 11, Issue 3, Pages (April 2015)
Volume 7, Issue 9, Pages (September 2014)
Volume 24, Issue 3, Pages (February 2013)
Volume 6, Issue 4, Pages (April 2010)
Volume 19, Issue 4, Pages (April 2014)
Control of the Embryonic Stem Cell State
Volume 16, Issue 3, Pages (March 2015)
Michal Levin, Tamar Hashimshony, Florian Wagner, Itai Yanai 
Genome-Wide Epigenetics
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 44, Issue 3, Pages (November 2011)
Volume 1, Issue 3, Pages (September 2007)
Volume 13, Issue 3, Pages (September 2013)
Volume 39, Issue 6, Pages (September 2010)
Volume 14, Issue 6, Pages (June 2014)
Volume 21, Issue 6, Pages e6 (December 2017)
Volume 132, Issue 6, Pages (March 2008)
Volume 122, Issue 6, Pages (September 2005)
Volume 35, Issue 2, Pages (August 2011)
Volume 14, Issue 6, Pages (June 2014)
Volume 21, Issue 6, Pages (December 2011)
Volume 6, Issue 5, Pages (May 2010)
Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells 
Volume 7, Issue 2, Pages (August 2010)
Multiple Epigenetic Modifiers Induce Aggressive Viral Extinction in Extraembryonic Endoderm Stem Cells  Michael C. Golding, Liyue Zhang, Mellissa R.W.
Volume 5, Issue 6, Pages (December 2015)
Long Noncoding RNAs in Cell-Fate Programming and Reprogramming
Volume 32, Issue 2, Pages (October 2008)
Short Telomeres in ESCs Lead to Unstable Differentiation
Volume 1, Issue 3, Pages (September 2007)
Volume 17, Issue 3, Pages (September 2009)
A Role for Epigenetics in Psoriasis: Methylated Cytosine–Guanine Sites Differentiate Lesional from Nonlesional Skin and from Normal Skin  Johann E. Gudjonsson,
Volume 9, Issue 1, Pages (July 2017)
Volume 17, Issue 3, Pages (October 2016)
Volume 52, Issue 1, Pages (October 2013)
Polycomb Group Proteins Set the Stage for Early Lineage Commitment
Volume 24, Issue 8, Pages e7 (August 2018)
Heterogeneity of Embryonic and Adult Stem Cells
NuRD and Pluripotency: A Complex Balancing Act
The 3D Genome in Transcriptional Regulation and Pluripotency
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B. Baylin  Molecular Cell 
Volume 11, Issue 7, Pages (May 2015)
Kevin Huang, Guoping Fan  Cell Stem Cell 
Presentation transcript:

Volume 6, Issue 6, Pages 591-602 (June 2010) Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network  Aviva Presser Aiden, Miguel N. Rivera, Esther Rheinbay, Manching Ku, Erik J. Coffman, Thanh T. Truong, Sara O. Vargas, Eric S. Lander, Daniel A. Haber, Bradley E. Bernstein  Cell Stem Cell  Volume 6, Issue 6, Pages 591-602 (June 2010) DOI: 10.1016/j.stem.2010.03.016 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Gene Classification Based on Chromatin Provides Insights into the Developmental State of Wilms Tumor (A) Wilms tumors, normal kidney, and ESCs were clustered by K4me3 promoter states. The cluster tree depicts relationships among these different tissues. (B and C) Four gene sets were defined based on promoter chromatin states. For each set, chromatin profiles are shown for a typical gene. These profiles depict ChIP-Seq signals for the indicated modification. The x axis corresponds to genome position. The y axis corresponds to the number of sequenced ChIP fragments that overlap a given position (range = 0–12). Set 1 contains genes with broad K4me3 domains in Wilms tumor; it is enriched for known regulators of kidney and mesoderm development (top two categories shown). Set 2 contains genes with promoter K4me3 peaks in Wilms tumor and ESCs, but not in normal kidney; it is enriched for regulators of chromatin, transcription, and epigenetic processes. Set 3 contains genes with overlapping K4me3 and K27me3 in Wilms tumor, a subset of which is differentially expressed in kidney (see text and Figure 3). Set 4 contains genes with promoter K27me3 in Wilms tumor it is enriched for genes involved in distinct developmental processes. See also Figure S1, Tables S1–S5. Cell Stem Cell 2010 6, 591-602DOI: (10.1016/j.stem.2010.03.016) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 Domains of Modified Histones Identify Developmental Regulators in Wilms Tumor (A) Histograms depict the size distribution of K4me3-enriched regions in ESCs, Wilms tumor, fetal kidney, and normal kidney. In both ESCs and Wilms tumor, the most expansive regions correspond to developmental genes with critical roles in the respective cell types. 95th percentile values (5.4 kb for ESCs, 4.8 kb for Wilms tumor, and 3.9 kb for both fetal and normal kidney) are indicated on each plot. (B) Genomic views show K4me3 signal in Wilms tumor for a typical promoter (GAA) and for the kidney stem cell regulator SIX2. (C and F) K4me3 signal at the SIX2 and SOX11 loci in Wilms tumor compared to normal kidney. (D and G) Expression of SIX2 and SOX11 mRNA shown for a panel of renal tumors and tissues. Abbreviations: a, clear cell sarcoma of the kidney; b, collecting duct carcinoma; c, chromophobe renal cell cancer; conventional renal cell carcinoma; fetal kidney; d, renal lipoma; adult kidney; papillary renal cell carcinoma; e, renal oncocytoma; f, rhabdoid tumor of kidney; Wilms tumor. (E and H) Immunofluorescence images depict SIX2 and SOX11 protein expression in a WTX mutant Wilms tumor and fetal kidney. In Wilms tumor, SIX2 and SOX11 have similar expression in the blastemal compartment (dotted outlines). In fetal kidney both markers are adjacent to the surface of the organ where mesenchymal and epithelial precursors are located (dotted lines). Original magnification 200×. (I and J) Genomic views show noncoding RNA genes with broad K4me3 domains in Wilms tumor. See also Tables S6 and S7. Cell Stem Cell 2010 6, 591-602DOI: (10.1016/j.stem.2010.03.016) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 Gene Sets Defined by Chromatin State in Wilms Tumor Show Differential Expression Patterns in Normal and Malignant Kidney Tissues Row-normalized heat maps depict relative expression of genes in Set 1 and Set 3. Red indicates high levels of expression; blue indicates low or no expression. (A) Genes in Set 1 (broad K4me3) are preferentially expressed in Wilms tumor and fetal kidney (Yusenko et al., 2009). (B) Genes in Set 3 show relatively greater expression in adult kidney, and heterogeneous expression in conventional renal cell carcinoma (cRCC). See also Figure S2. Cell Stem Cell 2010 6, 591-602DOI: (10.1016/j.stem.2010.03.016) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 Chromatin Regulators in Wilms Tumor and ESCs Genomic views depict K4me3 and K27me3 signals for (A) HDAC4, (B) CBX2, and (C) JARID2, genes encoding key chromatin regulators that are common to Wilms tumor and ESCs, but inactive in normal kidney and adult renal cancers. The highlighted genes are examples of “embryonic” chromatin regulators active in Wilms tumor. See also Figure S3, Tables S8 and S9. Cell Stem Cell 2010 6, 591-602DOI: (10.1016/j.stem.2010.03.016) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 5 Protein Expression Patterns of Bivalent Genes in Wilms Tumor and Kidney Tissue Genomic views depict K4me3 and K27me3 signals for (A) KCNJ3 and (B) NR4A2 that are bivalent in the tumor cells (top panels). Variable transition to a more active chromatin state is evident in normal kidney, which is heterogeneous. Immunofluorescence images show expression of the corresponding proteins in Wilms tumor and normal kidney (bottom panels). The images reveal weak expression in tumor, consistent with the chromatin patterns, but strong staining of specific epithelial compartments of normal kidney (red signals). Nuclei are stained with DAPI (blue signal). Original magnification 400×. See also Figure S4. Cell Stem Cell 2010 6, 591-602DOI: (10.1016/j.stem.2010.03.016) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 6 Epigenetic Regulation in Wilms Tumor (A) Genomic view depicts K4me3 and K27me3 signals for the p16 tumor suppressor locus (CDKN2A). This locus remains intact in the tumor but is silenced by expansive K27me3 in a pattern reminiscent of normal stem cells. (B) Methylation-specific PCR (MSP) shows that the p16 locus remains unmethylated at the DNA level, a pattern typical of normal stem cells but distinct from many adult cancers. Bisulfite-converted DNA was amplified with primers specific for unmethylated (p16 U) or methylated (p16 M) versions of the locus. Gels show PCR products for unmethylated (U) and methylated (M) genomic DNA controls and three Wilms tumor samples. (C) Genomic views depict K4me3 and K27me3 signals for imprinted gene loci. IGF2, which has been causally implicated in Wilms tumor, is associated with a uniquely broad K4me3 domain in Wilms tumor. PEG3 also shows substantially more K4me3 in the tumor. Cell Stem Cell 2010 6, 591-602DOI: (10.1016/j.stem.2010.03.016) Copyright © 2010 Elsevier Inc. Terms and Conditions